Legendary Trader: “Buy These Three Stocks Before this September Event”

Luke Lango believes an event scheduled for mid-September is set to trigger a massive market shock, potentially defining the winners and losers for the rest of the year.  

Wed, September 11 at 8:00PM ET
 
 
 
 
Register Here
Healthcare Stocks Icon

Healthcare Stocks

Healthcare encompasses a wide range of organized services to prevent, treat, and diagnose medical needs and mental illnesses. The $336 billion market is expected to grow at a compound annual growth rate of 8% until 2030, demonstrating the necessity of adequate healthcare. Healthcare companies, ranging from retailer CVS to insurance giant UnitedHealth, provide these services to a massive customer base.

The words "recession proof" written on a pink sticky note. bulletproof stocks

7 Recession-Resistant Stocks to Hold Onto for Dear Life in 2024

These seven recession-resistant stocks offer stability and potential growth even in challenging economic conditions.

Interest rate and dividend concept. Businessman with percentage symbol and up arrow, Interest rates continue to increase, return on stocks and mutual funds, long term investment for retirement. Dividend stocks

7 Dependable Dividend Stocks for Long-Term Income

Explore the best dividend stocks for long-term income excelling in the healthcare, retail, tobacco and home improvement markets.

medicine research, pharmaceutical background, LJPC stock

3 Pharmaceutical Stocks That Can Surge Higher Even if The Markets Correct

These are the pharmaceutical stocks to buy as they represent undervalued companies with a deep clinical pipeline that will support growth.

Other industries you might be interested in

Icon depicting a DNA strand

Biotech

Marijuana leaf

Cannabis

Icon depicting pills

Psychedelics

Recent Healthcare Stocks Articles

Why Is Alaunos Therapeutics (TCRT) Stock Up 37% Today?

By William White, InvestorPlace Writer
Alaunos Therapeutics stock is up on Monday morning as shares of TCRT see heavy trading despite a lack of releases or filings.

7 Dividend Stocks I Wouldn’t Touch With a 10-Foot Pole

By Thomas Niel, InvestorPlace Contributor
Avoid these seven dividend stocks to sell at all costs, as their payouts may not be a sustainable as they seem.

The 3 Most Undervalued Penny Stocks to Buy in December

By Gabriel Osorio-Mazzilli, InvestorPlace Contributor
When economies are set to boom, undervalued penny stocks typically lead the way when it comes to equity rallies.

3 of the Most Attractive Dividend Stocks in the Pharma Space

By Muslim Farooque, InvestorPlace Contributor
Discover the resilience and growth potential of pharma dividend stocks, offering stability and consistency in the healthcare sphere.

Are November’s 3 Biggest Stock Losers Worth Snapping Up Now?

By Rich Duprey, InvestorPlace Contributor
The market was like an iceberg with only a few winners showing but that means there are a lot of the biggest stock losers worth getting now.

7 Undervalued Biotech Stocks That are Flying Under the Clinical Radar

By Josh Enomoto, InvestorPlace Contributor
With so many innovative firms skyrocketing this year, astute investors seeking compelling discounts may want to turn their attention to undervalued biotech picks. Just like…

3 S&P 500 Stocks That Are About to Get Absolutely Crushed

By Joel Baglole, InvestorPlace Contributor
Investors should be careful with these securities, each of which has been slumping and could fall further in the year ahead.

AI Meets Biotech: 3 Top Stocks Transforming Medical Science

By John Blankenhorn, InvestorPlace Contributor
The AI revolution is bringing big gains to biotechnology, including drugs, antibodies, and synthetic biology.

Pharma’s Frontline: 3 Stocks Driving Revolutionary Drug Development

By John Blankenhorn, InvestorPlace Contributor
These pharma stock leaders offer revolutionary treatments that could change the world of medicine (and investor's portfolios) for the better.

The 3 Most Undervalued Biotech Stocks to Buy in December

By Gabriel Osorio-Mazzilli, InvestorPlace Contributor
Biotech is an increasing area of interest in the financial markets, line your portfolio up with these winning biotech stocks.

Why Is Verrica Pharmaceuticals (VRCA) Stock Up 40% Today?

By Josh Enomoto, InvestorPlace Contributor
With Verrica Pharmaceuticals releasing positive Phase 3 trial results for a skin disease therapeutic, VRCA stock skyrocketed in response.

Invitae Layoffs 2023: What to Know About the Latest NVTA Job Cuts

By William White, InvestorPlace Writer
Invitae layoffs are a hot topic on Friday after the genetics company announced a 15% reduction of its workforce to reduce costs.

Why Is Mangoceuticals (MGRX) Stock Down 33% Today?

By William White, InvestorPlace Writer
Mangoceuticals stock is falling on Friday after the company put into effect a public offering for shares of MGRX.

Why Is Aadi Bioscience (AADI) Stock Down 56% Today?

By William White, InvestorPlace Writer
Aadi Bioscience stock is taking a beating on Friday as investors in AADI react negatively to interim data from a clinical trial.

The New Magnificent 7: 7 Stocks Rising to Prominence

By Alex Sirois, InvestorPlace Contributor
The next magnificent 7 stocks continue to rise to prominence and offer strong returns to investors and are generally stable.

Budding Potential: 3 Cannabis Stocks Poised for Growth in 2024

By Yiannis Zourmpanos, InvestorPlace Contributor
Are you looking for quality cannabis stocks in 2024? Here are three cannabis stocks poised for growth in 2024.

Mind-Bending Growth: 3 Psychedelic Stocks With Trippy Potential

By Rick Orford, InvestorPlace Contributor
The increased understanding and widespread acceptance of mental health concerns have put psychedelic stocks in the spotlight.

MRNA Stock Surges as Moderna Teams Up With Merck to Fight Cancer

By Chris MacDonald, InvestorPlace Contributor
Moderna is in focus after reporting positive results for its cancer treatment today, with MRNA stock surging more than 9%.

Cathie Wood Just Dumped $40 Million of Coinbase Global (COIN) Stock

By Dana Blankenhorn, InvestorPlace Contributor
Wood is moving away from fintech and Internet names like COIN stock. She's now favoring genomics and artificial intelligence companies.
Load More Articles